LENTIVEX
Live / Registered — Registered (as of 09 Jul 2024)
What this means for you
Registered since 09 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79359897
- Registration number
- 7435355
- Mark type
- Stylized text
- Filed
- 18 Nov 2022
- Published for opposition
- 23 Apr 2024
- Registered
- 09 Jul 2024
- Attorney of record
- John R. Schaefer
Goods and services
- Class 001 — Chemicals: Chemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical and non-veterinary purposes; chemical and biological reagents for scientific and research purposes; human and animal stem cells for non-medical and non-veterinary purposes; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal stem cells for scientific and research purposes; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations for scientific and research purposes
- Class 005 — Pharmaceuticals: Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal stem cells for medical and veterinary purposes; preparations of microorganisms for medical and veterinary purposes; viral vectors being tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids for medical and veterinary use being biological preparations for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases
- Class 042 — Scientific and technological services: Product design and development services relating to the creation and alteration of chemical and biological reagents; new product design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; new product design services relating to the creation and alteration of recombinant viruses; new product design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; design services relating to the creation and alteration of viral vectors being drug discovery services; information and advice relating to all the aforesaid services
Owner
Prosecution history
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Jan 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Dec 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Dec 2024 — FINAL DISPOSITION PROCESSED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 09 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 07 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 30 Apr 2024 — NOTIFICATION PROCESSED BY IB
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION
- 10 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB